This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The new cap will apply to AstraZeneca’s entire range of inhaler products including Symbicort, Breztri Aerosphere, and Airsupra inhalers.
